SCHEMBL14420173

SCHEMBL14420173

C=C(C)c1ccc2c(c1)/C(=C/CCN1CCC(c3ccc(Cl)cc3)(C(C)O)CC1)c1cccnc1CO2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 2/20 0.57
▸ CHRM2 P08172 1/20 0.53
▸ CCR5 P51681 1/20 0.53
▸ HRH1 P35367 6/20 0.37
▸ TBXA2R P21731 4/20 0.33
▸ ADRA1A P35348 2/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ USP2 O75604 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL655011 1.00 CCR1 (0.57) CCR1CHRM2CCR5HRH1TBXA2R
SCHEMBL655010 1.00 CCR1 (0.57) CCR1CHRM2CCR5HRH1TBXA2R
SCHEMBL654107 0.87 CCR1 (0.75) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL654106 0.87 CCR1 (0.75) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL13824233 0.85 CCR1 (0.60) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL10288257 0.83 CCR1 (0.60) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL12121902 0.82 CCR1 (0.62) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL14420165 0.82 CCR1 (0.60) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL15478407 0.82 CCR1 (0.76) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL10288261 0.81 CCR1 (0.59) CCR1CHRM2CCR5HRH1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271176-B2 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-09-18 — — US disclosed
Send feedback